IQVIA Holdings Inc. (IQV) Stock Price: $186.25+2.56 (+1.39%)
The total return cagr for IQVIA Holdings Inc. (IQV) stock is 20.84% over the past 12 months. The 3 year average growth rate is -3.40% and the 5 year cagr is -4.90%. Total return includes dividends reinvested.
The closing share price for IQVIA Holdings Inc. (IQV) stock was $186.25 for Tuesday, June 9, 2026, up +1.39% from the previous day.
IQV Price Chart
IQV Key Metrics
See All MetricsIQV Earnings Preview
Next Earnings Date
Jul 21, 2026
42 days away
EPS Estimate
3.03
Revenue Est.
$4.31B
Last Quarter Results
EPS
$2.90
vs Estimate
$2.82
Revenue
$4.15B
vs Estimate
$4.10B
IQV Analyst Ratings
Consensus Rating
Based on 20 analysts
Average Price Target
$227.10
+21.9% upside
Low
$195.00
Current
$186.25
High
$287.00
IQV Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2028 | N/A | $3.53 | N/A | 7 |
| Q2 2028 | N/A | $3.72 | N/A | 6 |
| Q3 2028 | N/A | $3.95 | N/A | 6 |
| Q4 2028 | N/A | $4.41 | N/A | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $14.15 | N/A | 15 |
| FY 2028 | N/A | $15.73 | N/A | 8 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2028 | N/A | $4.63B | N/A | 7 |
| Q2 2028 | N/A | $4.76B | N/A | 6 |
| Q3 2028 | N/A | $4.79B | N/A | 6 |
| Q4 2028 | N/A | $4.97B | N/A | 7 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $18.25B | N/A | 15 |
| FY 2028 | N/A | $19.24B | N/A | 8 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
IQV Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1IQV | $31.09B | $186.25 | +1.39% | +20.84% | -4.90% | +10.84% |
IQV Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib